Emagine Solutions Technology, an award-winning medical software device company located in Tucson, announced that it has received clearance from the U.S. Food & Drug Administration (“FDA”) to market its VistaScan mobile ultrasound platform. Continue reading
Author Archive: AZBio
Arizona Legislators – Champions for Children With Rare Diseases
Saturday, February 29, 2020 is Rare Disease Day. At the Arizona Legislature, SB1571 , sponsored by Senator Kate Brophy McGee, would expand Arizona’s ability to screen newborns for two serious and too often deadly rare diseases, SMA and X-ALD so that they can be detected and treated early, providing there children with a better chance at healthier lives. The bill passed unanimously out of the Senate Health and Human Services Committee and is moving through the legislative process. Continue reading
Your Opportunity to Virtually Join the Arizona MedTech Thank You Tour
This week AZBio will be in Washington, D.C. meeting with our Arizona Congressional Delegation and thanking them for their work and support in permanently repealing the Medical Device Excise Tax. AZBio will be joining medtech leaders from across the country as part of the annual AdvaMed Fly-In. Even if you are not able to be with us LIVE in Washington, D.C. you can share your thanks with your Representative and Senators electronically by clicking here. Continue reading
Flinn Foundation Bioscience Entrepreneurship Program Welcomes 2020 Cohort
Six bioscience startups creating innovative solutions to improve regenerative medicine, spinal surgery, sleep health, medical payments, the food supply, and ear cleaning have been selected for the 2020 Flinn Foundation Bioscience Entrepreneurship Program.Continue reading
Discount Tire Partners with TGen to Create a Personalized Screening and Prevention Plan for Cancer Risk
Pilot study to focus on family history of relevant diseases and genetic risk scoreContinue reading
Sanofi joins forces with U.S. Department of Health and Human Services to advance a novel coronavirus vaccine
Work with Biomedical Advanced Research and Development Authority (BARDA) will utilize Sanofi’s well-established recombinant technology platform to expedite a potential COVID-19 vaccine
Continue reading
Getting a head start – The Advantages of New Born Screening
The purpose of newborn screening is to detect potentially fatal or disabling conditions in newborns as early as possible, often before the infant displays any signs or symptoms of a disease or condition. Arizona Legislators and Patient Advocates are working together to ensure Arizona babies are tested for additional conditions where early intervention can make a world of difference for patients and their families. Continue reading
AZBio Begins Data Gathering for Biennial Workforce Report
Talent is essential for every industry. Every two years, AZBio, in partnership with the Coalition of State Bioscience Institutes (CSBI) takes a look at the talent we have and the talent we need to grow great companies that make life better. Now is the time when your company can join the study.Continue reading
Unique Ways to Save on AZBio Membership
Is it time to renew your AZBio Membership? Did you know that by signing up for AZBio Programs with BIO Business Solutions®, many members will save MORE than the cost of their annual membership dues when they use these programs for AZBio Members?Continue reading
Skysong Innovations Completes Licensing Agreement with ASU Spinout OncoMyx Therapeutics
Immunotherapy company backed by $25 million in Series A financing is developing cancer treatments based on novel ASU technology. OncoMyx Therapeutics is an ASU spinout company founded on the myxoma virus (MYXV) platform.